Welcome to our dedicated page for Ufp Technologies news (Ticker: UFPT), a resource for investors and traders seeking the latest updates and insights on Ufp Technologies stock.
UFP Technologies Inc. reports developments for a contract development and manufacturing organization focused on single-use and single-patient medical devices. Company news commonly covers quarterly and annual results, non-GAAP measures such as adjusted EBITDA and adjusted EPS, program ramps, backlog commentary, acquisition integration, and manufacturing capacity tied to medical-device customers.
Updates also include customer supply agreements, new program launches, investor conference participation, and governance matters such as executive succession planning. The company's products and components are used across medical device, wound care, infection prevention, minimally invasive surgery, wearable, orthopedic soft-goods, and orthopedic implant-packaging applications.
UFP Technologies reported a net income of $13.4 million ($1.77 per share) for the year ended December 31, 2020, down from $19.8 million ($2.63 per share) in 2019. Sales decreased by 9.6% to $179.4 million. In Q4 2020, net income fell to $4.2 million ($0.55 per share), down from $5.8 million in Q4 2019. Medical sales dropped 6.8% for the year, primarily due to a decline in elective surgeries. However, the Product Development business surged 63%. The company noted improvements in gross margins and expressed optimism for a rebound in sales by Q4 2021.
UFP Technologies (Nasdaq: UFPT) will participate in the virtual Southwest IDEAS Investor Conference on November 18, 2020. Jeff Bailly, CEO, and Ron Lataille, CFO, will present, with the webcast starting at 7:00 am CST. The presentation will be accessible to registered participants via the conference portal and the company's investor relations website. One-on-one meetings with investors will also be hosted throughout the day. Interested investors can contact Jeff Elliott at Three Part Advisors at 972-423-7070 for participation details.
UFP Technologies (Nasdaq: UFPT) reported a third-quarter net income of $3.0 million ($0.40 per diluted share), down from $5.6 million ($0.75 per diluted share) in Q3 2019. Sales declined by 12.3% to $43.3 million, compared to $49.4 million in the same quarter last year. Year-to-date net income fell to $9.2 million from $14.0 million in 2019. Cost-saving initiatives, including workforce reduction, resulted in $5 million in annualized savings. The company holds $20 million in cash and zero debt, maintaining a focus on strategic acquisitions for future growth.
UFP Technologies (NASDAQ: UFPT), a leader in custom manufacturing for the medical market, will host virtual one-on-one meetings with investors on August 27, 2020, during the Midwest IDEAS Investor Conference. CFO Ron Lataille will represent the company at this event. Investors can contact Jeff Elliott from Three Part Advisors to schedule meetings. UFP specializes in advanced materials like foams and plastics, serving various sectors, including aerospace, automotive, and electronics.
UFP Technologies (UFPT) reported Q2 2020 net income of $2.3 million ($0.31 per share), down from $4.6 million ($0.62 per share) in Q2 2019. Sales decreased 17% to $42.6 million versus $51.4 million in the prior year. For the first half of 2020, net income fell to $6.2 million from $8.3 million, while sales declined 7.9% to $90.9 million. The automotive market saw a significant 70% drop, while medical sales only fell 4.2%. Despite challenges, there was a 35% increase in product development revenue. The company maintains a strong cash position of over $12 million, enhancing its growth potential.
UFP Technologies (Nasdaq: UFPT) will host virtual one-on-one meetings with investors at the East Coast IDEAS Investor Conference on June 23-24, 2020. CFO Ron Lataille will lead the discussions, aimed at demonstrating the company's investment potential. UFP Technologies specializes in designing and manufacturing components for the medical market using advanced materials and techniques. The IDEAS Conferences are influential venues for showcasing quality companies to investment professionals, featuring sponsors with over $200 billion in assets under management.